· Volume surge · RGC
Regencell Bioscience Holdings Ltd (RGC) volume swells as weekly slide deepens
The healthcare name is under broad pressure across one-, four- and twelve-week measures, with trend and strength readings still weak.
Regencell Bioscience Holdings Ltd (RGC) closed at 6.480 USD for the week ended June 26, leaving the stock down -46.0% over one week. The weekly price path over 52 weeks frames the move as a longer-context breakdown, not intraday trading action.
Turnover rose to 2.19 million shares, about 2.9 times the 13-week average of roughly 751,000. Market Dynamics at -1.46 signals continued pressure, while Relative Strength at -72.5 and an inactive trend signal add little confirmation of stabilization.